🚨 Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children

Nature Medicine, Published online: 24 August 2026; doi:10.1038/s41591-026-04664-4In a case series of an adult and four children with high- to intermediate-risk exposure to Bundibugyo ebolavirus, emergency use post-exposure prophylaxis monoclonal antibody cocktail (MBP134) treatment was well tolerated with no evidence of Bundibugyo virus disease, supporting future evaluation of MBP134 as a post-exposure prophylaxis for outbreaks.

This is a developing story.

Source: Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus…